AAWH — what changed in the latest 10-Q

Text added vs the prior filing · source: 10-Q · 2026-08-12

• Our consumer products portfolio is generated primarily from plant material that we grow and process ourselves. We have current production capacity across five manufacturing facilities with approximately 230,000 square feet of total canopy. This total excludes approximately 30,000 square feet of cano…

• During the three and six months ended June 30, 2026 and 2025, we sold a total of approximately 63,000 and 119,000 pounds of wholesale product, on a gross basis, respectively, compared to 56,000 and 112,000 pounds sold during the three and six months ended June 30, 2025, respectively. Our product por…

• In April 2026, Northeast Retail Partner Seven (as defined in Note 8, “Variable Interest Entities” in the Financial Statements) entered into a definitive agreement to acquire two adult-use dispensaries (“Northeast Partnership Dispensaries Seven and Eight”), which agreement is subject to regulatory ap…

• In May 2026, Midwest Retail Partner Two, as described in Note 8, “Variable Interest Entities,” entered into a definitive agreement to acquire four adult-use dispensaries (the “Midwest Partnership Two Dispensaries”), which agreement is subject to regulatory approval. The parties also entered into a m…

• The total consideration for the Midwest Partnership Two Dispensaries was determined to have an estimated fair value of $22,300. Of the total consideration, a deposit of $3,200 was remitted during the three months ended March 31, 2026 and $2,500 was remitted during the three months ended June 30, 202…

Text removed vs the prior filing · source: 10-Q · 2026-05-13

• Our consumer products portfolio is generated primarily from plant material that we grow and process ourselves. As of March 31, 2026, we produce our consumer packaged goods in six manufacturing facilities with approximately 260,000 square feet of total canopy. We sold approximately 56,000 pounds of w…

• On April 23, 2026, the U.S. Department of Justice (the “DOJ”) issued an order placing cannabis products subject to qualifying state medical cannabis licenses and other cannabis products that are FDA-approved into Schedule III under the Controlled Substances Act (21 U.S.C. § 801 et seq.) (the “CSA”) …

• General and administrative expenses increased by $5,261, or 14%, during the three months ended March 31, 2026, as compared to the three months ended March 31, 2025. The increase was primarily driven by:

• •a $2,066 increase in overhead expenses, including $2,314 of expenses associated with a rebalancing of certain overhead expenses from cost of goods sold, as well as costs associated with the expansion of operations, partially offset by ongoing cost control initiatives;

• •$1,848 of higher compensation expenses in support of the expansion of consolidated operations;

Text added vs the prior filing · source: 10-Q · 2026-08-12

• The legal basis for the April 2026 Order is subject to active litigation. If the April 2026 Order is enjoined, narrowed, or vacated, tax positions or operational decisions we take in reliance on it may be reversed, and we could be required to amend tax filings, recognize additional tax liabilities, …

Text removed vs the prior filing · source: 10-Q · 2026-05-13

• The legal basis for the April 2026 Order is expected to be challenged in litigation. If the April 2026 Order is enjoined, narrowed, or vacated, tax positions or operational decisions we take in reliance on it may be reversed, and we could be required to amend tax filings, recognize additional tax li…